MRE11A mutation
|
Small Cell Lung Cancer
|
MRE11A mutation
|
Small Cell Lung Cancer
|
olaparib Sensitive: C2 – Inclusion Criteria
|
olaparib Sensitive: C2 – Inclusion Criteria
|
MRE11A mutation
|
Mesothelioma
|
MRE11A mutation
|
Mesothelioma
|
olaparib Sensitive: C3 – Early Trials
|
olaparib Sensitive: C3 – Early Trials
|
MRE11A mutation
|
Endometrial Cancer
|
MRE11A mutation
|
Endometrial Cancer
|
talazoparib Sensitive: D – Preclinical
|
talazoparib Sensitive: D – Preclinical
|